RITECEFF CV TAB

About

RITECEFF CV TAB combines Cefixime, a third-generation cephalosporin antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. Cefixime works by inhibiting bacterial cell wall synthesis, providing broad-spectrum activity against many gram-positive and gram-negative bacteria. Clavulanic acid protects cefixime from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending its spectrum of activity to include many beta-lactamase-producing strains that would otherwise be resistant to cefixime alone.

This combination is particularly effective in treating a range of bacterial infections where beta-lactamase production is suspected or confirmed. It is commonly used for respiratory tract infections, urinary tract infections, and certain skin and soft tissue infections, offering enhanced efficacy against resistant pathogens and providing a robust oral treatment option.

Uses

• Treatment of complicated urinary tract infections.
• Management of respiratory tract infections (e.g., bronchitis, sinusitis).
• Therapy for otitis media caused by resistant strains.
• Treatment of certain skin and soft tissue infections.

Directions For Use

Take this medication orally as prescribed by your doctor, usually with or without food. Complete the full course of treatment even if symptoms improve.

Benefits

• Broad-spectrum antibacterial activity.
• Effective against beta-lactamase producing bacteria.
• Enhanced efficacy against resistant pathogens.
• Convenient oral administration.
• Useful for various common infections.
• Generally well-tolerated.

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Headache
• Dizziness
• Rash
• Flatulence
• Indigestion
• Vaginal candidiasis
• Elevated liver enzymes
• Allergic reactions

Safety Measures

• Alcohol - No specific interaction with alcohol is known. However, alcohol may exacerbate gastrointestinal side effects.
• Pregnancy - Should be used during pregnancy only if clearly needed and after consulting a healthcare professional, as data on this specific combination is limited.
• Breastfeeding - Both components are excreted in small amounts into breast milk. Use with caution and monitor the infant for potential gastrointestinal disturbances or allergic reactions.
• Liver - Use with caution in patients with liver impairment. Monitor liver function during prolonged therapy, especially in those with pre-existing hepatic conditions.
• Kidney - Dose adjustment is necessary in patients with significant renal impairment to prevent accumulation and potential toxicity of both cefixime and clavulanic acid.
• Lung - No specific contraindications or special precautions related to pre-existing lung conditions are generally noted for this combination.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.